Company news

Cardiff Oncology, Inc. news in 2025

Cardiff Oncology, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025

December 8, 2025

Cardiff Oncology to Present at Sidoti’s Year-End Virtual Investor Conference

December 8, 2025

Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference

November 24, 2025

Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update

November 6, 2025

Cardiff Oncology to Participate in Two Upcoming Investor Conferences

November 4, 2025

Cardiff Oncology to Participate in Three Upcoming Investor Conferences

August 28, 2025

Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)

July 29, 2025

Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update

July 29, 2025

Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC

June 17, 2025

Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025

June 2, 2025

Cardiff Oncology Reports First Quarter 2025 Results and Provides Business Update

May 8, 2025

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

April 23, 2025

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

April 15, 2025

Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

April 15, 2025

Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

February 27, 2025

Cardiff Oncology to Present at Upcoming Investor Conferences

February 24, 2025

Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update

February 20, 2025

Calls in 2025

Decks in 2025